Absorption | Not Available | |||||||||||||||
Volume of distribution | Not Available | |||||||||||||||
Protein binding | Not Available | |||||||||||||||
Metabolism | Hepatic. The main metabolite is N-desmethyladinazolam. The other two metabolites are alpha-hydroxyalprazolam and estazolam.
| |||||||||||||||
Route of elimination | Not Available | |||||||||||||||
Half life | Less than 3 hours. | |||||||||||||||
Clearance | Not Available | |||||||||||||||
Toxicity | Signs of overdose may include muscle weakness, ataxia, dysarthria and particularly in children paradoxical excitement. In more severe cases diminished reflexes, confusion, and coma may ensue. | |||||||||||||||
Affected organisms |
| |||||||||||||||
Pathways | Not Available |
Adinazolam
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment